Lobbying client
VERTANICAL GMBH
Biopharmaceutical company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.
Filings
11
Filed by
3
Reported in-house
—
Reported by firms
$300,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2023 to 2025
Filings
11 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination 3rd Quarter 2025
|
ALPINE GROUP PARTNERS, LLC. | $60,000 reported |
|
2nd Quarter - Report 2nd Quarter 2025
|
ALPINE GROUP PARTNERS, LLC. | $40,000 reported |
|
Registration 2nd Quarter 2025
|
ALPINE GROUP PARTNERS, LLC. | — reported |
|
4th Quarter - Termination (No Activity) 4th Quarter 2023
|
DLA PIPER LLP (US) | — reported |
|
3rd Quarter - Report 3rd Quarter 2023
|
DLA PIPER LLP (US) | $50,000 reported |
|
3rd Quarter - Termination 3rd Quarter 2023
|
VENABLE LLP | $50,000 reported |
|
3rd Quarter - Reportreplaced 3rd Quarter 2023
|
VENABLE LLP | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2023
|
DLA PIPER LLP (US) | $30,000 reported |
|
2nd Quarter - Report 2nd Quarter 2023
|
VENABLE LLP | $70,000 reported |
|
Registration 2nd Quarter 2023
|
VENABLE LLP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| VENABLE LLP | 2 | $120,000 |
| ALPINE GROUP PARTNERS, LLC. | 2 | $100,000 |
| DLA PIPER LLP (US) | 3 | $80,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Pharmacy | PHA | 7 |
| Health Issues | HCR | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.